AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Salarius Pharmaceuticals, Inc. Director's Dealing 2016

Jun 9, 2016

Director's Dealing

Opens in your device viewer

Issuer: Flex Pharma, Inc. (FLKS)
CIK: 0001615219
Period of Report: 2016-06-08

Reporting Person: Stacy Michelle (Director)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-08	Stock Option (right to buy)	$12.21	A	10000	Acquired	2026-06-08	Common Stock (10000.0)	Direct

F1: The stock option will vest in 12 successive equal monthly installments measured from June 8, 2016.